Interestingly, in HD transgenic mice, abnormally increased SGPL1 expression was observed at a very early stage of disease while SPHK1 and SPHK2 levels were not affected, suggesting that the process of dysregulation of S1P metabolism may begin very early in the disease process with alterations in expression SPHK1 and SPHK2 appearing as the disease progresses (Di Pardo et al., 2017). The gene discussed is SPHK1; the disease is Huntington disease.